Mitochondrial Transfer into Human Oocytes Improved Embryo Quality and Clinical Outcomes in Recurrent Pregnancy Failure Cases
International Journal of Molecular Sciences · 01.02.2023 · 24 (3) · 2738
DOI: 10.3390/ijms24032738 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.02.2023. Verfasst von Yoshiharu Morimoto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, HORAC Grand Front Osaka Clinic, Osaka 530-0011, Japan. Hauptthemen laut MEDLINE: Semen, Fertilization in Vitro. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
One of the most critical issues to be solved in reproductive medicine is the treatment of patients with multiple failures of assisted reproductive treatment caused by low-quality embryos. This study investigated whether mitochondrial transfer to human oocytes improves embryo quality and provides subsequent acceptable clinical results and normality to children born due to the use of this technology. We transferred autologous mitochondria extracted from oogonia stem cells to mature oocytes with sperm at the time of intracytoplasmic sperm injection in 52 patients with recurrent failures (average 5.3 times). We assessed embryo quality using the following three methods: good-quality embryo rates, transferable embryo rates, and a novel embryo-scoring system (embryo quality score; EQS) in 33 patients who meet the preset inclusion criteria for analysis. We also evaluated the clinical outcomes of the in vitro fertilization and development of children born using this technology and compared the mtDNA sequences of the children and their mothers. The good-quality embryo rates, transferable embryo rates, and EQS significantly increased after mitochondrial transfer and resulted in 13 babies born in normal conditions. The mtDNA sequences were almost identical to the respective maternal sequences at the 83 major sites examined. Mitochondrial transfer into human oocytes is an effective clinical option to enhance embryo quality in recurrent in vitro fertilization-failure cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, HORAC Grand Front Osaka Clinic, Osaka 530-0011, Japan.
- Department of Research, HORAC Grand Front Osaka Clinic, Osaka 530-0011, Japan.
- Reproductive Science Institute, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
- Department of Obstetrics and Gynecology, Nippon Life Hospital, Osaka 550-0006, Japan.
- Department of Obstetrics and Gynecology, IVF Namba Clinic, Osaka 550-0015, Japan.
- Department of Research, IVF Namba Clinic, Osaka 550-0015, Japan.
ORCID-Profile: Yoshiharu Morimoto, Shu Hashimoto
Zitieren
APA
Morimoto, Y., Gamage, U. S. K., Yamochi, T., Saeki, N., Morimoto, N., Yamanaka, M., Koike, A., Miyamoto, Y., Tanaka, K., Fukuda, A., Hashimoto, S., & Yanagimachi, R. (2023). Mitochondrial Transfer into Human Oocytes Improved Embryo Quality and Clinical Outcomes in Recurrent Pregnancy Failure Cases. International Journal of Molecular Sciences, 24(3), 2738. https://doi.org/10.3390/ijms24032738
Vancouver
Morimoto Y, Gamage USK, Yamochi T, Saeki N, Morimoto N, Yamanaka M, et al. Mitochondrial Transfer into Human Oocytes Improved Embryo Quality and Clinical Outcomes in Recurrent Pregnancy Failure Cases. International Journal of Molecular Sciences. 2023;24(3):2738. doi:10.3390/ijms24032738
BibTeX
@article{Morimoto2023,
author = {Morimoto, Yoshiharu and Gamage, Udayanga Sanath Kankanam and Yamochi, Takayuki and Saeki, Noriatsu and Morimoto, Naoharu and Yamanaka, Masaya and Koike, Akiko and Miyamoto, Yuki and Tanaka, Kumiko and Fukuda, Aisaku and Hashimoto, Shu and Yanagimachi, Ryuzo},
title = {Mitochondrial Transfer into Human Oocytes Improved Embryo Quality and Clinical Outcomes in Recurrent Pregnancy Failure Cases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2738},
doi = {10.3390/ijms24032738}
}
EUVIMED